{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:26:58Z","timestamp":1790252818568,"version":"4.1.0"},"reference-count":53,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2022,8,31]]},"DOI":"10.5582\/irdr.2022.01093","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T18:11:03Z","timestamp":1661364663000},"page":"96-104","source":"Crossref","is-referenced-by-count":32,"title":["Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision"],"prefix":"10.5582","volume":"11","author":[{"given":"Yanqin","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, Shandong, China."},{"name":"Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Gao","sequence":"additional","affiliation":[{"name":"Neck-Shoulder and Lumbocrural Pain Hospital, Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhi","family":"Ren","sequence":"additional","affiliation":[{"name":"Orthopedic Surgery, The People's Hospital of Wuqing District, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, Shandong, China."},{"name":"Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Melnikova I. Rare diseases and orphan drugs. Nature Reviews Drug Discovery. 2012; 11:267-268.","DOI":"10.1038\/nrd3654"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet. 2020; 28:165-173.","DOI":"10.1038\/s41431-019-0508-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. He J, Tang M, Zhang X, Chen D, Kang Q, Yang Y, Hu J, Jin C, Song P. Incidence and prevalence of 121 rare diseases in China: Current status and challenges. Intractable Rare Dis Res. 2019; 8:89-97.","DOI":"10.5582\/irdr.2019.01066"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shourick J, Wack M, Jannot AS. Assessing rare diseases prevalence using literature quantification. Orphanet J Rare Dis. 2021; 16:139.","DOI":"10.1186\/s13023-020-01639-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. He J, Kang Q, Hu J, Song P, Jin C. China has officially released its first national list of rare diseases. Intractable Rare Dis Res. 2018; 7:145-147.","DOI":"10.5582\/irdr.2018.01056"},{"key":"6","unstructured":"6. Bureau of Medical Administration, National Health Commission. Notice on issuance of the first list of rare diseases. http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201806\/393a9a37f39c4b458d6e830f40a4bb99.shtml <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"7","unstructured":"7. Yuan P, Li Z, Xia T, Li H. Population investigation of albinism in China for 25 years- Review and future. Chin J Birth Health & Heredity. 2006; 4-6."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 6:60.","DOI":"10.1186\/1750-1172-6-60"},{"key":"9","unstructured":"9. Taiwan Health Promotion Administration. Statistical Table of Reported Cases of Rare Diseases. https:\/\/www.hpa.gov.tw\/Pages\/Detail.aspx?nodeid=1559&pid=10254 <\/i>(accessed March 10, 2019). (in Chinese)"},{"key":"10","unstructured":"10. Ding J, Wang L. 121 Rare Diseases Handbook. China Medical Science and Technology Press. Beijing, 2019."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhan S, Siu J, Wang Z, Yu H, Bezabeh T, Deng Y, Du W, Fei P. Focal point of Fanconi anemia signaling. Int J Mol Sci. 2021; 22.","DOI":"10.3390\/ijms222312976"},{"key":"12","unstructured":"12. Berry GT. Classic galactosemia and clinical variant galactosemia. In: GeneReviews (Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds.). Seattle (WA), 1993."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pillai NR, Stroup BM, Poliner A, Rossetti L, Rawls B, Shayota BJ, Soler-Alfonso C, Tunuguntala HP, Goss J, Craigen W, Scaglia F, Sutton VR, Himes RW, Burrage LC. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review. Mol Genet Metab. 2019; 128:431-443.","DOI":"10.1016\/j.ymgme.2019.11.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Li Q, Yang C, Feng L, Zhao Y, Su Y, Liu H, Men H, Huang Y, Korner H, Wang X. Glutaric acidemia, pathogenesis and nutritional therapy. Front Nutr. 2021; 8:704-984.","DOI":"10.3389\/fnut.2021.704984"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Racis L, Tessa A, Di Fabio R, Storti E, Agnetti V, Casali C, Santorelli FM, Pugliatti M. The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy. J Neurol. 2014; 261:52-59.","DOI":"10.1007\/s00415-013-7151-4"},{"key":"16","unstructured":"16. The Subspecialty Group of Endocrinology H, and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association. Common sense in diagnosis and treatment of hyperphenylalaninemia. Chin J Ped. 2014; 420-425."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021; 10.","DOI":"10.3390\/jcm10235676"},{"key":"18","unstructured":"18. Ye L, Yuan H, Cai X. Analysis of screening results for 21-hydroxylase deficiency in newborns in the Dongguan area. Contemporary Medicine Forum. 2014; 164-165."},{"key":"19","unstructured":"19. Pan L, Zheng M, Xie L, Cai R, Tan J, Yang J, Huang L. Screening for 21-hydroxylase deficiency in newborns in Liuzhou. Chin J Birth Health & Heredity. 2013; 68-69."},{"key":"20","unstructured":"20. Wang C. A retrospective study of rare diseases in China Biology Medicine Database. Master's Thesis, Jinan University. 2015."},{"key":"21","unstructured":"21. Chen J. Treatable Rare Diseases (Chen J, eds.). Shanghai Jiao Tong University Press, Shanghai, China. 2017; 38-136."},{"key":"22","unstructured":"22. Roberts AE. Noonan syndrome. In: GeneReviews (Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds.). University of Washington, Seattle (WA), 1993."},{"key":"23","unstructured":"23. Zhang SY. Compendium of China's First List of Rare Disease. People's Medical Publishing House. Beijing, 2018."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hosahalli Vasanna S, Pereda MA, Dalal J. Clinical features, cancer biology, transplant approach and other integrated management strategies for Wiskott-Aldrich syndrome. J Multidiscip Healthc. 2021; 14:3497-3512.","DOI":"10.2147\/JMDH.S295386"},{"key":"25","unstructured":"25. Shanghai Municipal Health Commission. Notice on printing and distribution of the List of Major Rare Diseases in Shanghai<\/i> (2016 Edition). http:\/\/wsjkw.sh.gov.cn\/fybj2\/20180815\/0012-59645.html<\/i> (accessed March 10, 2022). (in Chinese)"},{"key":"26","unstructured":"26. Liu X. Descriptive epidemiology investigation and analysis of the rare diseases in eight provinces, China. China Academic Journal Electronic Publishing House. 2016."},{"key":"27","unstructured":"27. Chinese Organization for Rare Disorders. Reference list of rare diseases in China. https:\/\/www.sohu.com\/a\/114982149_119250 (accessed March 10, 2022). (in Chinese)"},{"key":"28","unstructured":"28. General Office, National Health Commission. Notice on publication of the Rare Diseases Diagnosis and Treatment Guide (2019). http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201902\/61d06b4916c348e0810ce1fceb844333.shtml <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"29","unstructured":"29. Bureau of Medical Administration, National Health Commission. Notice on the establishment of a national cooperative network for the diagnosis and treatment of rare diseases. http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201910\/be9343380e414adb8c8d641ae8967492.shtml <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"30","unstructured":"30. Bureau of Medical Administration, National Health Commission. Notice on the registration of information on the diagnosis and treatment of rare diseases. http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201910\/be9343380e414adb8c8d641ae8967492.shtml <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"31","unstructured":"31. Department of Publicity, National Health Commission. Transcript of the State Council Information Office's regular policy briefing on July 8, 2021. http:\/\/www.nhc.gov.cn\/xcs\/s3574\/202107\/8c7bce96b85c48498df15fb1bd0434eb.shtml<\/i> (accessed March 10, 2022). (in Chinese)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Guo J, Liu P, Chen L, Lv H, Li J, Yu W, Xu K, Zhu Y, Wu Z, Tian Z, Jin Y, Yang R, Gu W, Zhang S. National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses. Orphanet J Rare Dis. 2021; 16:515.","DOI":"10.1186\/s13023-021-02130-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lu Y, Han J. The definition of rare disease in China and its prospects. Intractable Rare Dis Res. 2022; 11:29-30.","DOI":"10.5582\/irdr.2022.01034"},{"key":"34","unstructured":"34. Xiao J, Wang C. Support system for rare disease prevention and protection: Experience in Taiwan and insights. Social Security Studies. 2018; 2:92-105."},{"key":"35","unstructured":"35. Ministry of Health of the People's Republic of China. Report on the control of birth defects in China 2012. http:\/\/www.gov.cn\/gzdt\/att\/att\/site1\/20120912\/1c6f6506c7f811bacf9301.pdf <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"36","unstructured":"36. Foundation for Intervention in and Relief of Birth Defects in China. Birth defect (genetic metabolic disease) relief project. http:\/\/www.csqx.org.cn\/list.aspx?id=877919995095&prjid=48###<\/i> (accessed March 10, 2022). (in Chinese)"},{"key":"37","unstructured":"37. Ding J WL. Report of rare diseases in China (2018) (Ding J, Wang L, eds). China Medical Science Press, Beijing, 2018; 9."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhao H, Cui Y, Zhou X, Pang J, Zhang X, Xu S, Han J. Study and analysis of the state of rare disease research in Shandong Province, China. Intractable Rare Dis Res. 2012; 1:161-166.","DOI":"10.5582\/irdr.2012.v1.4.161"},{"key":"39","unstructured":"39. Shi XM LH, Wang L, Wang ZX, Dong CY, Wang YF, Yao C, Zhan SY, Ding J, Li Y. Study on the current situation of China's First List of Rare Diseases based on 15 million hospitalizations. Natl Med J China 2018; 98:3274-3278."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Cai X, Genchev GZ, He P, Lu H, Yu G. Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai. Orphanet J Rare Dis. 2021; 16:262.","DOI":"10.1186\/s13023-021-01830-4"},{"key":"41","unstructured":"41. Hubei Daily. "Survey of rare diseases in Hubei Province" released. http:\/\/www.shandong.gov.cn\/art\/2017\/3\/2\/art_97564_280621.html?from=singlemessage&isappinsta lled=0 <\/i>(accessed March 10, 2022). (in Chinese)"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tsai CP, Wang KC, Hwang CS, Lee IT, Lee CT. Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999-2008. J Formos Med Assoc. 2015; 114:612-619.","DOI":"10.1016\/j.jfma.2013.01.008"},{"key":"43","unstructured":"43. Zhang SY. Compendium of China's First List of Rare Disease (Zhang SY, eds.). People's Medical Publishing House, Beijing, 2018; 86-503."},{"key":"44","unstructured":"44. Lu H, Zheng J, Yao Y, Yang M, Ya S, Shi N, Lu J. Retrospective analysis of screening results using TMS to identify inherited metabolic diseases in newborns in Yancheng. Chin J Birth Health & Heredity. 2016; 83-85."},{"key":"45","unstructured":"45. Li Y, Cui W, Ya X, Wang H. Epidemiology of congenital scoliosis in Luohe. Chin J Ped Surg. 2017; 221-224."},{"key":"46","unstructured":"46. Qu Y, Nie X, Yang Z, Zhan S. Meta-analysis of the prevalence of hemophilia in mainland China. Chin J Hematol. 2014; 65-68."},{"key":"47","unstructured":"47. Zhao Z. Advances in screening newborns for inherited metabolic diseases. Chin J Pract Ped. 2014; 586-589."},{"key":"48","unstructured":"48. Liu X. Descriptive epidemiology investigation and analysis of the rare disease in eight provinces, China. Master's Thesis, Pharmacy, Jinan University. 2016."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Tu TC, Liou WS, Chou TY, Lin TK, Lee CF, Chen JD, Cham TM, Chung MI. Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan. Yonsei Med J. 2013; 54:71-80.","DOI":"10.3349\/ymj.2013.54.1.71"},{"key":"50","unstructured":"50. Ling S, Chan G, Shing M, Yue H, Lee A, Chan C, Lee C, Kwong K, Li C. Children and adolescents with haemophilia in Hong Kong: An epidemiological and clinical review. Hong Kong J Paed. 2006; 13-19."},{"key":"51","unstructured":"51. Zhou H, Li Y, Tian L. Progress in diagnosis and treatment of medium-chain acyl-coenzyme A dehydrogenase deficiency. Chin J Pract Ped. 2019; 22-25."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Lau KK, Wong WW, Sheng B, Yu IT, Fung BH, Li HL, Ma KF, Wong LK, Li PC. The clinical course of multiple sclerosis patients in Hong Kong. J Neurol Sci. 2008; 268:78-82.","DOI":"10.1016\/j.jns.2007.11.006"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. You QS, Xu L, Wang YX, Liang QF, Cui TT, Yang XH, Wang S, Yang H, Jonas JB. Prevalence of retinitis pigmentosa in North China: The Beijing Eye Public Health Care Project. Acta Ophthalmol. 2013; 91:e499-500.","DOI":"10.1111\/aos.12163"}],"container-title":["Intractable & Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/11\/3\/11_2022.01093\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:42:54Z","timestamp":1715218974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/11\/3\/11_2022.01093\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2022.01093","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"article-number":"2022.01093"}}